School of Medicine


Showing 101-200 of 208 Results

  • Chad S. Weldy, M.D., Ph.D.

    Chad S. Weldy, M.D., Ph.D.

    Instructor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsAs a physician-scientist in the lab of Dr. Quertermous I work to understand the genetic basis of cardiovascular disease and the transcriptional and epigenomic mechanisms of atherosclerosis. My work is focused across four main areas of cardiovascular genetics and mechanisms of coronary artery disease and smooth muscle biology:
    1.Vascular smooth muscle specific ADAR1 mediated RNA editing of double stranded RNA and activation of the double stranded RNA receptor MDA5
    2.Defining on single cell resolution the cellular and epigenomic features of human vascular disease across vascular beds of differing embryonic origin
    3.CRISPRi screening with targeted perturb seq (TAPseq) to identify novel CAD genes in human coronary artery smooth muscle cells
    4.Investigation of the epigenetic and molecular basis of coronary artery disease and smooth muscle cell transition in mice with conditional smooth muscle genetic deletion of CAD genes Pdgfd and Sox9

    My work with Dr. Quertermous is focused on discovery of causal mechanisms of disease through leveraging human genetics with sophisticated molecular biology, single cell sequencing technologies, and mouse models of disease. This work attempts to apply multiple scientific research arms to ultimately lead to novel understandings of vascular disease and discover important new therapeutic approaches for drug discovery.

    Grant funding received for this work:

    Mentored Clinical Scientist Research Career Development Award (K08)(NIH/NHLBI, 1 K08 HL167699-01), Submitted June, 2022. PI: Weldy, Chad
    •Title of proposal: “ADAR Mediated RNA editing is a causal mechanism in coronary artery disease”.
    •Pending 08/01/2023 Start date
    •$850,000 over 5 years

    Career Development Award, American Heart Association (AHA CDA)(23CDA1042900), July, 2023 – June, 2026. PI: Weldy, Chad
    •Title of proposal: “Linking RNA editing to coronary artery calcification and disease”
    •Activation on 07/01/2023
    •$231,000 over three years

    NIH Loan Repayment Program (LRP) Award (NIH/NHLBI) Renewal Award, July, 2023. PI: Weldy, Chad
    •Title of proposal: “RNA editing is a causal mechanism of coronary artery disease”

    Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (NIH/NHLBI, 1 F32 HL160067-01), July, 2021. PI: Weldy, Chad
    • Titled, “A transcriptional network which governs smooth muscle transition is mediated by causal coronary artery disease gene PDGFD”
    •*Received perfect score with impact score 10, 1st percentile

    NIH Loan Repayment Program (LRP) Award (NIH/NHLBI), July, 2021. PI: Weldy, Chad
    •Title of proposal: "Single cell transcriptomic and epigenomic features of human atherosclerosis".
    •This will award up to $100,000 towards student loans over the next 24 months with opportunity for renewal after 24 months.

  • Andy Wen

    Andy Wen

    Clinical Associate Professor, Pediatrics - Critical Care

    BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine as Clinical Associate Professor of Pediatrics in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.

    After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).

    While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.

    At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital.

  • Paul Wender

    Paul Wender

    Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis

  • Kirsti Weng Elder MD/MPH

    Kirsti Weng Elder MD/MPH

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioDr. Weng is the Section Chief of General Primary Care. She has over 25 years of experience caring for patients in primary care, urgent care and in the hospital. She is also a teacher of students and residents. As a leader in primary care re-design, she is passionate about practicing patient-centered medicine. She is a an advocate of Mindfulness Self-compassion to develop equanimity. She practices with an emphasis on musculoskeletal care as she feels fitness is the foundation of wellness. She is a leader in organizational change and physician management. She supports community health and care for the underserved. Outside of work she enjoys biking, reading and spending time with her 8 children.

  • Wen-Kai Weng, MD, PhD

    Wen-Kai Weng, MD, PhD

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology

    Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.

  • Gerlinde Wernig

    Gerlinde Wernig

    Assistant Professor of Pathology

    Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.

  • Marius Wernig

    Marius Wernig

    Professor of Pathology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine

  • Dee W. West

    Dee W. West

    Professor of Health Research and Policy, Emeritus

    Current Research and Scholarly Interests- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer
    - Cancer surveillance (Cancer registration, cancer patterns)
    - Cancer outcomes (Survival, quality of life, quality of care)

  • Robert West

    Robert West

    Professor of Pathology

    Current Research and Scholarly InterestsRob West, MD, PhD, is a Professor of Pathology at Stanford University Medical Center. He is a clinician scientist with experience in translational genomics research to identify new prognostic and therapeutic markers in cancer. His research focus is on the progression of neoplasia to carcinoma. His lab has developed spatially oriented in situ methods to study archival specimens. He also serves as a surgical pathologist specializing in breast pathology.

  • Cornelia Weyand

    Cornelia Weyand

    Professor of Medicine (Immunology and Rheumatology), Emerita

    Current Research and Scholarly InterestsAutoimmunity
    Chronic inflammatory disease
    Metabolic control of immune function

  • Matthew Wheeler

    Matthew Wheeler

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsTranslational research in rare and undiagnosed diseases. Basic and clinical research in cardiomyopathy genetics, mechanisms, screening, and treatment. Investigating novel agents for treatment of hypertrophic cardiomyopathy and new mechanisms in heart failure. Cardiovascular screening and genetics in competitive athletes, disease gene discovery in cardiomyopathy and rare disease. Informatics approaches to rare disease and multiomics. Molecular transducers of physical activity bioinformatics.

  • Lee White, Ph.D.

    Lee White, Ph.D.

    Clinical Scholar, Urology
    Fellow in Graduate Medical Education

    BioI am a fourth year clinical medical student at Stanford University School of Medicine. Here you will find out about my interests including a list of my publications and projects. I completed my doctoral research on training and evaluation of robotic surgical techniques with the Biorobotics Lab at the University of Washington in Spring 2013. I am a co-founder of C-SATS, Inc., a surgical performance assessment company that uses expert reviews and the wisdom of the crowd to train surgeons and medical practitioners.

  • Ian Whitmore

    Ian Whitmore

    Professor (Teaching) of Surgery (Anatomy)
    On Leave from 05/15/2024 To 08/25/2024

    Current Research and Scholarly InterestsThe development of better regimes for teaching Anatomy using Cadavers.

  • Alice S Whittemore

    Alice S Whittemore

    Professor of Health Research and Policy (Epidemiology) and of Biomedical Data Science, Emerita
    Professor Emerita, Epidemiology and Population Health

    Current Research and Scholarly InterestsCancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers.

  • Aileen Whyte

    Aileen Whyte

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    BioDr. Aileen Whyte, a licensed psychologist in California, brings over two decades of specialized expertise to the treatment of eating disorders in young people. Beyond her clinical practice, Dr. Whyte actively works on implementing strategies to expand the reach of evidence-based treatments for eating disorders, aiming to make these best-practice interventions more accessible to a wider population.

    Dr Whyte serves as the Director of the Stanford Outpatient Child & Adolescent Eating Disorders Clinic, where she provides treatment to young people with eating disorders and provides supervision to psychology and psychiatry fellows. Dr Whyte is a certified practitioner and consultant in Family-Based Treatment (FBT) for eating disorders. She serves as a study therapist in NIMH-sponsored randomized clinical trials focused on examining FBT and related adaptations.

    In addition to her clinical responsibilities, Dr. Whyte has led multiple seminars, workshops, and training sessions dedicated to the treatment of eating disorders. She provides ongoing training and consultation in FBT, reaching diverse audiences, including multidisciplinary clinicians, psychologists, and psychiatrists, within the US and internationally.

    Dr. Whyte earned her PhD in Clinical Psychology from the New School for Social Research in New York. Her research and clinical interests converge on the implementation and dissemination of evidence-based treatments for eating disorders.

  • Jennifer Williams

    Jennifer Williams

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Williams is a fellowship-trained pulmonologist specializing in pulmonary critical care medicine. She has board certification in pulmonary medicine, critical care medicine, and internal medicine.

    She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine.

    For each patient, Dr. Williams develops a comprehensive and compassionate care plan. Her goal is to help every individual achieve the best possible lung health and quality of life.

    Patient reviews praise the quality of the care she delivers, her thoroughness, and her patient skills.

    Dr. Williams has participated in clinical research studies. She has published articles on autoimmune disease involving interstitial lung disease, COPD, and life-threatening pulmonary complications associated with leukemia. She also co-authored an article on the development of guidelines for identifying and managing post-traumatic stress disorder symptoms associated with critical illness.

    Her work has appeared in peer-reviewed journals including the American Journal of Respiratory and Critical Care Medicine, Internal Medicine, and elsewhere. She also has written chapters in books on critical care medicine and clinical decision-making.

    Dr. Williams speaks English and both written and oral medical Spanish. In her free time, she enjoys soccer and distance running.

  • Leanne Williams

    Leanne Williams

    Vincent V.C. Woo Professor, Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and, by courtesy, of Psychology

    Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.

  • Nolan Williams

    Nolan Williams

    Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator) and, by courtesy, of Radiology (Neuroimaging and Neurointervention)

    BioNolan Williams, M.D. is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
    Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
    His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show.

  • Sarah R. Williams MD, MHPE, PCC

    Sarah R. Williams MD, MHPE, PCC

    Clinical Professor, Emergency Medicine

    Current Research and Scholarly InterestsExploring ways to incorporate coaching into medical education.

    Investigating ways to innovate medical education training across specialties.

    Investigating applications of clinician-performed point-of-care ultrasound for emergency and critical care patients.

    Improving safety of transitions of care between providers during sign-out.

  • Sharon E. Williams PhD

    Sharon E. Williams PhD

    Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    Current Research and Scholarly InterestsDr. Williams’ work focuses primarily on cognitive and emotional recovery of children who have been medically compromised. With improved medical treatment and increased survival rates comes the need to better understand the challenges that patients face following a life threatening illness or injury. Dr. Williams utilizes neuropsychological assessments to understand the cognitive abilities of children who have been diagnosed with cancer, head injuries, genetic disorders and other medical conditions.

  • Julie Williamson, DO, FAAP

    Julie Williamson, DO, FAAP

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
    Clinical Associate Professor (By courtesy), Pediatrics - Critical Care

    BioDr. Williamson practices pediatric anesthesiology and critical care. She is committed to undergraduate and graduate medical education, and has served as an Educator-for-CARE at the Stanford School of Medicine and as a program director for Anesthesiology at Emory University. She is affiliated with several mentoring and advising programs, including the Stanford Anesthesiology Mentoring Program and the Women's Empowerment and Leadership Initiative for Pediatric Anesthesiologists.

  • Darrell Wilson

    Darrell Wilson

    Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly InterestsMy research interests cover a number of areas in Pediatric Endocrinology and Diabetes. I am PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes. I am an investigator in DirecNet, another NIH-funded study group, which is devoted to evaluating glucose sensors and the role of technology on the management of diabetes.

  • Helen Wilson

    Helen Wilson

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Wilson is a licensed clinical psychologist with expertise on the effects of trauma across the lifespan. She provides clinical services for children, adolescents, adults, and families affected by trauma and other forms of anxiety and stress. Dr. Wilson also leads an active research program focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood. She is the Principal Investigator of GIRLTALK: We Talk, a longitudinal study funded by the National Institute of Child Health and Human Development (NICHD) that examines links from childhood violence exposure to dating violence and sexual risk in young women from low-income communities in Chicago. Dr. Wilson has authored or co-authored thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is on the editorial board of the Journal of Youth and Adolescence.

  • Jennifer Wilson MD, MS

    Jennifer Wilson MD, MS

    Clinical Associate Professor, Emergency Medicine

    Current Research and Scholarly InterestsEmergency critical care & resuscitation, ARDS, sepsis

  • Edward N. Wilson

    Edward N. Wilson

    Instructor, Neurology & Neurological Sciences

    Current Research and Scholarly InterestsSingle-cell transcriptomic profiling of immune cells in Alzheimer's disease brain

    Alzheimer's disease, Parkinson's disease and multiple sclerosis biomarkers

    Alzheimer’s disease experimental therapeutics

  • Thomas J. Wilson

    Thomas J. Wilson

    Clinical Associate Professor, Neurosurgery

    BioDr. Thomas J. Wilson was born in Omaha, Nebraska. He attended the University of Nebraska College of Medicine, earning his MD with highest distinction. While a medical student, he was awarded a Howard Hughes Medical Institute Research Training Fellowship and spent a year in the lab of Dr. Rakesh Singh at the University of Nebraska. He was also elected to the prestigious Alpha Omega Alpha Honor Medical Society. He completed his residency training in neurological surgery at the University of Michigan and was mentored by Dr. Lynda Yang and Dr. John McGillicuddy in peripheral nerve surgery. Following his residency, he completed a fellowship in peripheral nerve surgery at the Mayo Clinic in Rochester, Minnesota, working with Dr. Robert Spinner. He is now Clinical Associate Professor and Co-Director of the Center for Peripheral Nerve Surgery at Stanford University. He also holds a Master of Public Health (MPH) degree from the Bloomberg School of Public Health at Johns Hopkins University, with focused certificates in Clinical Trials and Health Finance and Management. His research interests include peripheral nerve outcomes research, clinical trials advancing options for patients with peripheral nerve pathologies and spinal cord injuries, and translational research focused on improved imaging techniques to assist in diagnosing nerve pain and other peripheral nerve conditions. His clinical practice encompasses the treatment of all peripheral nerve pathologies, including entrapment neuropathies, nerve tumors, nerve injuries (including brachial plexus injuries, upper and lower extremity nerve injuries), and nerve pain. Dr. Wilson enjoys working in multi-disciplinary teams to solve complex problems of the peripheral nervous system. His wife, Dr. Monique Wilson, is a practicing dermatologist in the Bay Area.

  • Shannon Wiltsey Stirman

    Shannon Wiltsey Stirman

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsThe overarching goal of my program of research is to determine how to facilitate access to evidence-based psychosocial interventions (EBPs) in community and public sector mental health settings. Areas of emphasis include training and consultation, treatment fidelity and adaptation, AI and digital mental health interventions, and the identification of strategies that promote sustained implementation of EBPs.

  • Jeffrey J. Wine

    Jeffrey J. Wine

    Benjamin Scott Crocker Professor of Human Biology, Emeritus

    Current Research and Scholarly InterestsThe goal is to understand how a defective ion channel leads to the human genetic disease cystic fibrosis. Studies of ion channels and ion transport involved in gland fluid transport. Methods include SSCP mutation detection and DNA sequencing, protein analysis, patch-clamp recording, ion-selective microelectrodes, electrophysiological analyses of transmembrane ion flows, isotopic metho

  • Carl Gustaf Winge,MD PhD

    Carl Gustaf Winge,MD PhD

    Clinical Instructor, Dermatology

    BioMårten Winge, M.D. Ph.D., is a Clinical Instructor of Dermatology and conducts research in the laboratory of Dr Paul Khavari at Stanford, where he studies epidermal differentiation. Dr Winge completed his M.D. and Ph.D studies at Karolinska Institute in Sweden, and subsequently a research fellowship followed by dermatology residency at Stanford. His clinical interests include inflammatory skin disease as well as skin cancer.

  • Marilyn Winkleby, PhD, MPH

    Marilyn Winkleby, PhD, MPH

    Professor (Research) of Medicine (Stanford Prevention Research Center), Emerita

    Current Research and Scholarly InterestsCardiovascular disease epidemiology, health of socioeconomically disadvantaged and ethnic minority populations, social determinants of health, community-based intervention research, youth advocacy and mentorship, promoting diversity in health professions

  • Virginia D. Winn, MD, PhD

    Virginia D. Winn, MD, PhD

    Associate Professor of Obstetrics and Gynecology (Reproductive and Stem Cell Biology)

    Current Research and Scholarly InterestsThe Winn Laboratory seeks to understand the unique biological mechanisms of human placentation. While the placenta itself is one of the key characteristics for defining mammals, the human placenta is different from most available animal models: it is one of the most invasive placentas, and results in the formation of an organ comprised of cells from both the fetus and the mother. In addition to this fascinating chimerism, fetal cells are deeply involved in the remodeling of the maternal vasculature in order to redirect large volumes of maternal blood to the placenta to support the developing fetus. As such, the investigation of this human organ covers a large array of biological processes, and deals not only with understanding its endocrine function, but the physiologic process of immune tolerance, vascular remodeling, and cellular invasion.

  • Terry Winograd

    Terry Winograd

    Professor of Computer Science, Emeritus

    BioProfessor Winograd's focus is on human-computer interaction design and the design of technologies for development. He directs the teaching programs and HCI research in the Stanford Human-Computer Interaction Group, which recently celebrated it's 20th anniversary. He is also a founding faculty member of the Hasso Plattner Institute of Design at Stanford (the "d.school") and on the faculty of the Center on Democracy, Development, and the Rule of Law (CDDRL)

    Winograd was a founding member and past president of Computer Professionals for Social Responsibility. He is on a number of journal editorial boards, including Human Computer Interaction, ACM Transactions on Computer Human Interaction, and Informatica. He has advised a number of companies started by his students, including Google. In 2011 he received the ACM SIGCHI Lifetime Research Award.

  • Dean Winslow

    Dean Winslow

    Professor of Medicine (Hospital Medicine), by courtesy, of Pediatrics (Infectious Diseases) and Senior Fellow, by courtesy, at the Freeman Spogli Institute for International Studies

    BioDean Winslow, MD is Professor of Medicine and Pediatrics and is a Senior Fellow (courtesy) at CISAC/Freeman Spogli Institute. He has served on the Stanford faculty since 1998 and from 2003-2008 as Co-Director of Stanford's Infectious Diseases Fellowship Training Program. He was in private practice in Wilmington, Delaware where he started the state’s first multidisciplinary clinic for HIV patients in 1985. In 1988 he joined the DuPont Company where he worked both as a bench scientist on HIV drug resistance then designed the clinical trials supporting FDA approval of efavirenz. In 1999 he became Vice President of Regulatory Affairs at Visible Genetics Inc. and led the FDA clearance of the TRUGENE HIV-1 drug resistance test. Dr. Winslow joined the staff at Santa Clara Valley Medical Center in 2003, where he served as Chief of the Division of AIDS Medicine and later as Chair of the Department of Medicine. In 2015 he was appointed Vice Chair of the Department of Medicine at Stanford and Academic Physician-In-Chief at Stanford/ValleyCare. He was a Resident Fellow in Robinson House 2013-2017 and was visiting faculty at Oxford University in 2017. He was Lead Physician for the US Antarctic Program of the National Science Foundation 2019-2020 based at McMurdo Station, Antarctica. In 2021 he took leave from Stanford to lead the US COVID-19 Testing and Diagnostic Working Group. He also served as CDC Senior Advisor to Operation ALLIES WELCOME and Chief Medical Officer for the Southwest Border Migrant Health Task Force before returning to Stanford in July 2022.

    Dr. Winslow is a Master of the American College of Physicians, Fellow of the Royal College of Physicians, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society. He is the author of 94 papers. He is,a member of the IDSA Sepsis Task Force, and previously served as Chair of the Standards and Practice Guidelines Committee.

    Colonel Winslow entered the Air National Guard in 1980 and was a Distinguished Graduate of the USAF School of Aerospace Medicine. He served as Commander of the 159th Medical Group 1992-1995 and was State Air Surgeon, Delaware Air National Guard 1995-2011. He served as ANG Assistant to the Commander, 59th Medical Wing, Joint Base San Antonio 2011-2014. Colonel Winslow deployed to the Middle East six times after 9/11 as a flight surgeon supporting combat operations in Iraq and Afghanistan. From Jan-April 2003 Colonel Winslow was the flight surgeon responsible for combat rescue operations from northern Iraq to Tikrit. In 2005 he coordinated military public health in Louisiana in the aftermath of Hurricane Katrina. In 2006 Colonel Winslow served as an ER physician at the United States Air Force 447th EMEDS (combat hospital) in Baghdad and in 2008 he served as hospital commander during the Iraq surge. He is a 2007 graduate of Air War College. He served as an infectious disease consultant to the USAF Surgeon General. In 2017 Dr. Winslow was nominated by the President to serve as Assistant Secretary of Defense for Health Affairs. He has 3,000 civilian and 1150 military flying hours including 431 combat hours and 263 combat sorties. He has extensive operational experience in fighter, tactical airlift, and combat rescue missions. He holds an FAA Airline Transport Pilot license.

    Since 2006 Dr. Winslow has arranged medical care in the U.S. for 28 Iraqi children who have complicated medical conditions for which care is not available in Iraq. In 2015, Dr. Winslow and his wife, Dr. Julie Parsonnet, created The Eagle Fund of the Silicon Valley Community Foundation, which provides aid to middle eastern and central American refugees. In 2018 he co-founded Scrubs Addressing the Firearms Epidemic (SAFE), which unites health care professionals to address gun violence in the US as a public health issue and to advocate for education, research, and evidence-backed policy to reduce gun violence.

  • Monte Winslow

    Monte Winslow

    Associate Professor of Genetics and of Pathology

    Current Research and Scholarly InterestsOur laboratory uses genome-wide methods to uncover alterations that drive cancer progression and metastasis in genetically-engineered mouse models of human cancers. We combine cell-culture based mechanistic studies with our ability to alter pathways of interest during tumor progression in vivo to better understand each step of metastatic spread and to uncover the therapeutic vulnerabilities of advanced cancer cells.

  • Paul H. Wise, MD, MPH

    Paul H. Wise, MD, MPH

    Richard E. Behrman, MD, Professor of Child Health and Society, Professor of Health Policy and Senior Fellow at the Freeman Spogli Institute for International Studies
    On Leave from 02/01/2024 To 12/20/2024

    Current Research and Scholarly InterestsHe is a health policy and outcomes researcher whose work has focused on children's health; health-outcomes disparities by race, ethnicity and socioeconomic status; the interaction of genetics and the environment as these factors influence child and maternal health; and the impact of medical technology on disparities in health outcomes.

  • Clay P. Wiske, MD

    Clay P. Wiske, MD

    Clinical Assistant Professor, Surgery - Vascular Surgery

    BioDr. Wiske is a vascular surgeon in the Vascular and Endovascular Care program at Stanford Health Care. He is also a clinical assistant professor of surgery in the Department of Surgery, Division of Vascular Surgery. Dr. Wiske manages and treats the full spectrum of vascular disease, performing both open and endovascular surgery.

    His clinical interests include peripheral arterial disease, venous disease, dialysis access, and aortic and peripheral aneurysms. Additionally, he has helped develop and evaluate medical devices designed to maximize the ease of treatment and limit the invasiveness of specific interventions.

    Dr. Wiske has published research on a variety of topics within vascular surgery. These include the best approaches to reduce the risk of stroke associated with carotid surgery and the impact of using multidisciplinary teams to identify and treat pulmonary embolisms. Dr. Wiske has also participated in studies assessing the pace of innovation in vascular surgery, as well as policy approaches to reducing the financial burden of health care on patients.

    Dr. Wiske has published his work in numerous peer-reviewed journals, including the Journal of the American Medical Association, the Journal of Vascular Surgery, and Vascular and Endovascular Surgery. He has also been an invited guest speaker at national and international meetings, including those for the Society for Vascular Surgery, American Venous Forum, and the Vascular and Endovascular Surgery Society.

  • John Witte

    John Witte

    Professor of Epidemiology and Population Health, of Biomedical Data Science and, by courtesy, of Genetics

    BioDr. Witte joined the Stanford community in July 2021. In addition to serving as Vice Chair and professor in the Department of Epidemiology & Population Health, and as a professor of Biomedical Data Science and, by courtesy, of Genetics, he will also serve as a member of the Stanford Cancer Institute.

    Dr. Witte is an internationally recognized expert in genetic epidemiology. His scholarly contributions include deciphering the genetic and environmental basis of prostate cancer and developing widely used methods for the genetic epidemiologic study of disease. His prostate cancer work has used comprehensive genome-wide studies of germline genetics, transcriptomics, and somatic genomics to successfully detect novel variants underlying the risk and aggressiveness of this common disease. A key aspect of this work has been distinguishing genetic factors that may drive increased prostate cancer risk and mortality among African American men. Providing an avenue to determine which men are more likely to be diagnosed with clinically relevant prostate cancer and require additional screening or specific treatment can help reduce disparities in disease prevalence and outcomes across populations. Dr. Witte has also developed novel hierarchical and polygenic risk score modeling for undertaking genetic epidemiology studies. These advances significantly improve our ability to detect disease-causing genes and to translate genetic epidemiologic findings into medical practice.

    Dr. Witte has received the Leadership Award from the International Genetic Epidemiology Society (highest award), and the Stephen B. Hulley Award for Excellence in Teaching. His extensive teaching portfolio includes a series of courses in genetic and molecular epidemiology. He has mentored over 50 graduate students and postdoctoral fellows, serves on the executive committees of multiple graduate programs, and has directed a National Institutes of Health funded post-doctoral training program in genetic epidemiology for over 20 years. Recently appointed to the National Cancer Institute Board of Scientific Counselors, Dr. Witte has been continuously supported by the National Institutes of Health.

  • Ronald Witteles

    Ronald Witteles

    Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly Interests1) Amyloidosis -- Optimizing diagnosis/therapy and discovering new treatments
    2) CardioOncology -- Understanding, treating, and preventing cancer therapy-induced cardiotoxicity
    3) Sarcoidosis -- Exploring novel diagnostic modalities and determining optimal treatment, with a focus on cardiac sarcoidosis

  • Temesgen 'Tem'  Woldeyesus

    Temesgen 'Tem' Woldeyesus

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Tem (Temesgen) is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health. He obtained his medical degree at UCSF and continued his residency training at UCSF in Family and Community Medicine. He was selected as Chief Resident, where he further developed as a clinical educator and administrator, prior to joining the faculty group at Stanford. His academic interests include alternative models of care, clinical informatics, and digital health equity.

    Dr. Tem Woldeyesus practices full-spectrum family medicine, which includes care for the entire age spectrum. He is driven to provide evidence-based, high quality, culturally competent care.

    He is a native of the Bay Area. Outside of work, he enjoys spending time with his fiancée, playing (and watching) basketball, and exploring national parks.

  • Albert J. Wong, M.D.

    Albert J. Wong, M.D.

    Professor of Neurosurgery

    Current Research and Scholarly InterestsOur goal is to define targets for cancer therapeutics by identifying alterations in signal transduction proteins. We first identified a naturally occurring mutant EGF receptor (EGFRvIII) and then delineated its unique signal transduction pathway. This work led to the identification of Gab1 followed by the discovery that JNK is constitutively active in tumors. We intiated using altered proteins as the target for vaccination, where an EGFRvIII based vaccine appears to be highly effective.

  • Becky Wong

    Becky Wong

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr. Becky Wong is board certified in adult and pediatric anesthesiology and practices anesthesiology at Stanford University Hospitals and Clinics and The Lucile Packard Children’s Hospital in Stanford, California. She received her medical school degree at The University of California at San Diego and her anesthesia residency and pediatric anesthesia fellowship training at Stanford. She provides anesthesia care for a wide range of ages with a focus on neuroanesthesia. She co-chairs the Neuroanesthesia Special Interest Group in the Society for Pediatric Anesthesia. As an Associate Director for Quality Improvement in the Stanford Anesthesia Department, she has a deep interest in improving patient care.

  • David J. Wong, MD, PhD

    David J. Wong, MD, PhD

    Clinical Associate Professor, Dermatology

    Current Research and Scholarly InterestsMy research interest is focused on investigating the molecular networks that underlie cancer stem cells and designing therapies that selectively target these cells, thereby eliminating a cancer's potential for regrowth.

  • Jadene Wong

    Jadene Wong

    Clinical Associate Professor, Pediatrics - Neonatal and Developmental Medicine
    Clinical Associate Professor, Pediatrics - General Pediatrics

    Current Research and Scholarly Interests- Care of the Infant with Neonatal Opioid Withdrawal Syndrome (NOWS)
    https://www.cpqcc.org/resources/neonatal-opioid-withdrawal-syndrome-nows-toolkit
    https://nastoolkit.org/
    https://podcasts.apple.com/us/podcast/episode-17-neonatal-abstinence-syndrome-dr-jadene-wong/id1581530231?i=1000558004429

    - Primary Care for Preterm Infants and Children
    https://www.cpqcc.org/preterm-primary-care-toolkit

  • Wing Hung Wong

    Wing Hung Wong

    Stephen R. Pierce Family Goldman Sachs Professor of Science and Human Health and Professor of Biomedical Data Science

    Current Research and Scholarly InterestsCurrent interest centers on the application of statistics to biology and medicine. We are particularly interested in questions concerning gene regulation, genome interpretation and their applications to precision medicine.

  • Jennifer Woo, MD

    Jennifer Woo, MD

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine
    Clinical Assistant Professor, Pediatrics - Cardiology

    BioDr. Woo is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. She is also a clinical assistant professor in the Divisions of Cardiovascular Medicine and Pediatric Cardiology at Stanford University School of Medicine.

    She diagnoses and treats a range of cardiovascular diseases, with a focus on adult congenital heart disease. Dr. Woo has Level III training with the National Board of Echocardiography, a certification that recognizes her experience in complex cardiac imaging. She also has specialized expertise in cardiac MRI. Each of her patients receives a personalized, comprehensive care plan delivered with compassion.

    Dr. Woo is heavily involved in adult congenital heart disease research. She has a particular interest in imaging and heart failure in adults with congenital heart disease. She has received grant funding for her work, including from the Adult Congenital Heart Association. The National Institutes of Health awarded granted her the Ruth L. Kirschstein National Research Service Award.

    She has published research in several peer-reviewed journals, such as the Journal of the American College of Cardiology and Pediatric Cardiology. Dr. Woo has presented her findings at regional and national meetings, including the Adult Congenital Heart Disease Bay Area Conference and the International Symposium on Adult Congenital Heart Disease.

    Dr. Woo is a member of the Adult Congenital Heart Association, American College of Cardiology, American Heart Association, and American Society of Echocardiography.

  • Joseph Woo, MD, FACS, FACC, FAHA

    Joseph Woo, MD, FACS, FACC, FAHA

    Norman E. Shumway Professor, Professor of Cardiothoracic Surgery and, by courtesy, of Bioengineering

    BioDr. Woo is a nationally recognized surgeon, innovator, researcher, and educator in cardiothoracic surgery.

    He chairs the Stanford Health Cardiothoracic Surgery Department. He is the Norman E. Shumway Professor of Cardiothoracic Surgery and holds a courtesy appointment in the Department of Bioengineering.

    Dr. Woo is a board-certified, fellowship-trained heart surgeon with an active clinical practice of more than 300 pump cases per year. He focuses on complex mitral and aortic valve repair, thoracic aortic surgery, cardiopulmonary transplantation, and minimally invasive surgery.

    He has advanced these fields by developing innovative surgical procedures. He serves as principal investigator on two studies funded by National Institutes of Health (NIH) grants. One explores stem cells, angiogenesis, tissue engineering, and valvular biomechanics. Dr. Woo has received NIH funding for this study continuously since 2004.

    He has served as primary investigator for clinical device trials. He also has been the primary investigator for translational scientific clinical trials entailing administration of stem cells during coronary artery bypass grafting and left ventricular arterial device (LVAD) implantation.

    Dr. Woo has co-authored more than 400 articles in peer-reviewed publications.
    Dr. Woo serves on the board of directors of the American Association for Thoracic Surgery (AATS). He is the president of the AATS Cardiac Surgery Biology Club. He is a fellow of the American College of Surgeons, American College of Cardiology, and American Heart Association. He serves on the leadership committee of the American Heart Association’s Council on Cardiovascular Surgery and Anesthesia.

    He is a member of the Society of Thoracic Surgeons, International Society for Minimally Invasive Cardiac Surgery, International Society for Heart & Lung Transplantation, International Society for Heart Research, and other professional societies.

  • Britt Wray

    Britt Wray

    Instructor, Psychiatry and Behavioral Sciences

    BioDr. Wray is the Director of CIRCLE at Stanford Psychiatry, a research and action initiative focused on Community-minded Interventions for Resilience, Climate Leadership and Emotional wellbeing in the Stanford School of Medicine. Before this she was a Human and Planetary Health Postdoctoral Fellow at the Stanford Center for Innovation in Global Health, Stanford Woods Institute for the Environment and London School of Hygiene & Tropical Medicine. Her research focuses on the mental health impacts of climate change on young people ('emerging adults') and frontline community members, community-minded psychosocial support interventions, and public engagement for improved mental and planetary health. She is the author of two books; her latest Generation Dread: Finding Purpose in an Age of Climate Anxiety, is an impassioned generational perspective on how to stay sane amid climate disruption and was a finalist for the 2022 Governor General’s Award. She is the recipient of the 2023 Canadian Eco-Hero Award and top award winner of the National Academies Eric and Wendy Schmidt Awards for Excellence in Science Communications, given by The National Academies of Sciences, Engineering, and Medicine. Her first book is Rise of the Necrofauna: The Science, Ethics and Risks of De-Extinction (Greystone Books 2017) and was named a "best book of the year" by The New Yorker. Dr Wray holds a PhD in Science Communication from the University of Copenhagen. She has hosted and produced several science radio programs, podcasts and television programs for international broadcasters including the BBC and CBC, and she has spoken at TED and the World Economic Forum. She is the Founder of Gen Dread (gendread.substack.com), a newsletter about building courage and taking meaningful action on the far side of climate grief.

  • Ana Vanessa Adams Wren

    Ana Vanessa Adams Wren

    Clinical Associate Professor, Pediatrics - Gastroenterology

    BioClinical Focus:
    Psychology
    Child and Adolescent Psychology
    Pediatric Pain Psychology
    Inflammatory Bowel Disease Psychology

  • Sherry M. Wren, MD, FACS, FCS(ECSA), FISS

    Sherry M. Wren, MD, FACS, FCS(ECSA), FISS

    Professor of Surgery (General Surgery)

    Current Research and Scholarly InterestsOur research interests are primarily in global surgery,robotics,surgical oncology, especially gastrointestinal cancers.

  • Hannah Wright

    Hannah Wright

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioHannah Wright, MMS, PA-C has been a practicing physician assistant since 2010. She received her PA education at Stanford and earned a Master of Medical Science degree from Saint Francis University. She has worked in Family Practice, Internal Medicine, Gynecology. Since 2013 she has worked in the Stanford Express Care Clinic. She is also a Clinical Instructor of Medicine and an E4C-PA in the Stanford Masters of Science in PA Studies Program.

  • John Fraser Wright

    John Fraser Wright

    Professor (Research) of Pediatrics (Stem Cell Transplantation)
    On Leave from 05/01/2024 To 06/30/2024

    BioJ Fraser Wright, PhD
    Dr. Wright received his PhD in 1989 from the University of Toronto (Biochemistry) for studies
    characterizing the interaction of complement with IgM, and completed post-doctoral studies at INSERM
    / CENG Grenoble, France in molecular immunology focused on antigen processing and presentation. He
    was awarded a CRCS/ MRC Scholarship, gaining faculty appointment at the University of Toronto. In
    1996 he joined industry as a Scientist at Pasteur Sanofi, contributing there to the development of
    vaccines and cancer immunotherapies, and subsequently as Director of Development and Clinical
    Manufacturing at Avigen, a gene therapy company that pioneered AAV-based investigational gene
    therapies for hemophilia and Parkinson’s disease. In 2004 he returned to academia, establishing and
    directing the Clinical Vector Facility at the Center for Cellular and Molecular Therapeutics at Children’s
    Hospital of Philadelphia, and gaining faculty appointment at the University of Pennsylvania Perelman
    School of Medicine as professor of Pathology and Laboratory Medicine. Dr. Wright has contributed to
    several clinical development programs in gene therapy, including for Luxturna and Kymriah, the first
    gene therapies for a genetic (RPE65 deficiency) and non-genetic (CAR-T immunotherapy) disease,
    respectively, approved in the United States, and for the first gene therapy clinical trial that delivered an
    AAV-vectorized monoclonal antibody to human subjects for HIV passive immunity. He is a Co-founder of
    Spark Therapeutics, serving there and subsequently at Axovant as Chief Technology Officer. In 2019 Dr.
    Wright joined Stanford University as Professor of Pediatrics at The Center for Definitive and Curative
    Medicine (CDCM). His research program aims to address key immunological barriers to gene therapy
    through innovative approaches to viral vector design and generation, and to develop vectorized
    antibodies for serious human diseases.

  • Albert Y. Wu, MD, PhD, FACS

    Albert Y. Wu, MD, PhD, FACS

    Assistant Professor of Ophthalmology

    Current Research and Scholarly InterestsMy translational research focuses on using autologous stem cells to recreate a patient’s ocular tissues for potential transplantation. We are generating tissue from induced pluripotent stem cells to treat limbal stem cell deficiency in patients who are bilaterally blind. By applying my background in molecular and cellular biology, stem cell biology, oculoplastic surgery, I hope to make regenerative medicine a reality for those suffering from orbital and ocular disease.

  • Bryan Wu, MD

    Bryan Wu, MD

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Wu is a board-certified cardiologist at Stanford Health Care. He is also a clinical assistant professor in the Division of Cardiovascular Medicine. His areas of clinical focus include general and preventive cardiology with a particular interest in cardiac imaging. Dr. Wu has board certification in echocardiography, cardiovascular CT, and cardiac nuclear imaging.

    Dr. Wu speaks fluent Chinese and Spanish and embraces racial, ethnic, and socioeconomic diversity in his clinical care. He has international clinical/research experiences in Italy and Mexico, and truly enjoys meeting and working with people from distinctive backgrounds.

    Dr. Wu is passionate about clinical research. He has pursued scholarly work on the utilization of therapeutic drug monitoring for antihypertensive therapy and statins to help patients from low socioeconomic backgrounds improve their medication adherence. He is also involved in research on advanced cardiac imaging and has actively investigated the applications of cardiac CT in electrophysiology interventions.

    Dr. Wu’s research has been published in peer-reviewed journals such as the International Journal of Cardiology and Journal of Vascular Surgery. He has presented his work at regional and national meetings, including the American Heart Association’s annual Scientific Sessions.

    Dr. Wu is a member of the American College of Physicians, American Heart Association, and American Medical Association.

  • Hsi-Yang Wu

    Hsi-Yang Wu

    Member, Bio-X

    Current Research and Scholarly InterestsI am interested in how the brain matures to control the bladder and external sphincter to achieve urinary continence. Using functional MRI of the brain, we are investigating if certain patterns of activity will predict which children will respond to therapy for incontinence.

  • Joseph  C. Wu, MD, PhD

    Joseph C. Wu, MD, PhD

    Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology

    Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.